Symptomtext
No additional AE's were reported and no additional AE details were provided.; was supposed to receive a dose of MMR-II and VARIVAX but received a dose of PROQUAD instead; PROQUAD administered to a 31-year-old woman; This spontaneous report was received from a medical assistance and refers to a 31-year-old female patient. The patient's concurrent conditions, medical history, concomitant medications, allergies and drug reactions were not provided. On 03-OCT-2022 (at the age of 31 years), the patient was vaccinated with a dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) subcutaneous injection, 0.5 milliliter, administered subcutaneously, lot #U039259, expiration date: 09-JUN-2023, (strength and anatomical site of vaccination were not provided) for prophylaxis (product administered to patient of inappropriate age). The patient was supposed to be vaccinated with a dose of rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) and a dose of varicella virus vaccine live (oka/merck) (VARIVAX) subcutaneous injection, but received a dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) instead (wrong product administered). The patient had not any side effects from the vaccine which she received. No additional adverse events (AEs) were reported (no adverse event) and no additional adverse event (AE) details were provided.